Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Topical sensitizers have mixed success in treating alopecia areata.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia is a key indicator of thallium poisoning.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

A genetic defect in vitamin D receptors causes severe rickets and hair loss in children, but some heal as they age.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Anthralin cream helped 25% of patients with severe alopecia areata regrow hair, but caused skin irritation.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Alopecia areata patients often have low vitamin D levels, suggesting they might benefit from vitamin D supplements.

PUVA treatment is generally ineffective for alopecia areata.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Minoxidil-loaded NLC gel shows potential for effective alopecia treatment.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.